<code id='6BB171CA22'></code><style id='6BB171CA22'></style>
    • <acronym id='6BB171CA22'></acronym>
      <center id='6BB171CA22'><center id='6BB171CA22'><tfoot id='6BB171CA22'></tfoot></center><abbr id='6BB171CA22'><dir id='6BB171CA22'><tfoot id='6BB171CA22'></tfoot><noframes id='6BB171CA22'>

    • <optgroup id='6BB171CA22'><strike id='6BB171CA22'><sup id='6BB171CA22'></sup></strike><code id='6BB171CA22'></code></optgroup>
        1. <b id='6BB171CA22'><label id='6BB171CA22'><select id='6BB171CA22'><dt id='6BB171CA22'><span id='6BB171CA22'></span></dt></select></label></b><u id='6BB171CA22'></u>
          <i id='6BB171CA22'><strike id='6BB171CA22'><tt id='6BB171CA22'><pre id='6BB171CA22'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:29572
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Medicare drug price negotiation hasn't dried up venture capital
          Medicare drug price negotiation hasn't dried up venture capital

          AdobeWASHINGTON—VenturecapitalistsarestillpouringmoneyintodrugresearchinspiteofMedicare’snewpowerton

          read more
          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more

          SEC charges former device maker CEO with $41 million fraud

          From2017to2020,Stimwaveimplantednearly8,000patientswithnervestimulatorscontainingdummypiecesofplasti